Global Cord Blood (NYSE:CO) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a research report report published on Wednesday. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Price Performance

CO opened at $1.15 on Wednesday. The company has a market cap of $139.78 million, a price-to-earnings ratio of 1.80 and a beta of 0.16. The firm has a 50 day simple moving average of $1.04 and a 200 day simple moving average of $1.32. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.